HALISTER: Celgene Sinks as Drug Doesn’t Extend Life in Blood Cancer Type

Celgene Sinks as Drug Doesn’t Extend Life in Blood Cancer Type

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
CELG US (Celgene Corp)

People
Mark Schoenebaum (Evercore Partners Inc)
Michael Yee (RBC Capital Markets)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283